Application 201374
- Type
- ANDA
- Sponsor
- ANCHEN PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | LAMOTRIGINE | LAMOTRIGINE | TABLET, EXTENDED RELEASE;ORAL | 25MG | No | No |
| 002 | LAMOTRIGINE | LAMOTRIGINE | TABLET, EXTENDED RELEASE;ORAL | 50MG | No | No |
| 003 | LAMOTRIGINE | LAMOTRIGINE | TABLET, EXTENDED RELEASE;ORAL | 100MG | No | No |
| 004 | LAMOTRIGINE | LAMOTRIGINE | TABLET, EXTENDED RELEASE;ORAL | 200MG | No | No |
| 005 | LAMOTRIGINE | LAMOTRIGINE | TABLET, EXTENDED RELEASE;ORAL | 250MG | No | No |
| 006 | LAMOTRIGINE | LAMOTRIGINE | TABLET, EXTENDED RELEASE;ORAL | 300MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A201374-001 | LAMOTRIGINE | LAMOTRIGINE | 25MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-12-26 | |
| A201374-002 | LAMOTRIGINE | LAMOTRIGINE | 50MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-12-26 | |
| A201374-003 | LAMOTRIGINE | LAMOTRIGINE | 100MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-12-26 | |
| A201374-004 | LAMOTRIGINE | LAMOTRIGINE | 200MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-12-26 | |
| A201374-005 | LAMOTRIGINE | LAMOTRIGINE | 250MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-12-26 | |
| A201374-006 | LAMOTRIGINE | LAMOTRIGINE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-12-26 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A201374-001 | AB |
| A201374-002 | AB |
| A201374-003 | AB |
| A201374-004 | AB |
| A201374-005 | AB |
| A201374-006 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A201374-001 | LAMOTRIGINE | 25MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-12-26 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A201374-002 | LAMOTRIGINE | 50MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-12-26 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A201374-003 | LAMOTRIGINE | 100MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-12-26 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A201374-004 | LAMOTRIGINE | 200MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-12-26 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A201374-005 | LAMOTRIGINE | 250MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-12-26 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A201374-006 | LAMOTRIGINE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-12-26 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A201374-001 | LAMOTRIGINE | 25MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-12-26 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A201374-002 | LAMOTRIGINE | 50MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-12-26 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A201374-003 | LAMOTRIGINE | 100MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-12-26 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A201374-004 | LAMOTRIGINE | 200MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-12-26 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A201374-005 | LAMOTRIGINE | 250MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-12-26 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A201374-006 | LAMOTRIGINE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-12-26 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A201374-001 | LAMOTRIGINE | 25MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-12-26 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A201374-002 | LAMOTRIGINE | 50MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-12-26 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A201374-003 | LAMOTRIGINE | 100MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-12-26 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A201374-004 | LAMOTRIGINE | 200MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-12-26 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A201374-005 | LAMOTRIGINE | 250MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-12-26 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A201374-006 | LAMOTRIGINE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2012-12-26 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A201374-001 | LAMOTRIGINE | 25MG | TABLET, EXTENDED RELEASE / ORAL | 2012-12-26 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A201374-002 | LAMOTRIGINE | 50MG | TABLET, EXTENDED RELEASE / ORAL | 2012-12-26 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A201374-003 | LAMOTRIGINE | 100MG | TABLET, EXTENDED RELEASE / ORAL | 2012-12-26 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A201374-004 | LAMOTRIGINE | 200MG | TABLET, EXTENDED RELEASE / ORAL | 2012-12-26 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A201374-005 | LAMOTRIGINE | 250MG | TABLET, EXTENDED RELEASE / ORAL | 2012-12-26 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A201374-006 | LAMOTRIGINE | 300MG | TABLET, EXTENDED RELEASE / ORAL | 2012-12-26 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A201374-001 | LAMOTRIGINE | 25MG | TABLET, EXTENDED RELEASE / ORAL | 2012-12-26 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A201374-002 | LAMOTRIGINE | 50MG | TABLET, EXTENDED RELEASE / ORAL | 2012-12-26 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A201374-003 | LAMOTRIGINE | 100MG | TABLET, EXTENDED RELEASE / ORAL | 2012-12-26 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A201374-004 | LAMOTRIGINE | 200MG | TABLET, EXTENDED RELEASE / ORAL | 2012-12-26 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A201374-005 | LAMOTRIGINE | 250MG | TABLET, EXTENDED RELEASE / ORAL | 2012-12-26 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A201374-006 | LAMOTRIGINE | 300MG | TABLET, EXTENDED RELEASE / ORAL | 2012-12-26 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A201374-001 | LAMOTRIGINE | 25MG | TABLET, EXTENDED RELEASE / ORAL | 2012-12-26 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A201374-002 | LAMOTRIGINE | 50MG | TABLET, EXTENDED RELEASE / ORAL | 2012-12-26 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A201374-003 | LAMOTRIGINE | 100MG | TABLET, EXTENDED RELEASE / ORAL | 2012-12-26 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A201374-004 | LAMOTRIGINE | 200MG | TABLET, EXTENDED RELEASE / ORAL | 2012-12-26 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A201374-005 | LAMOTRIGINE | 250MG | TABLET, EXTENDED RELEASE / ORAL | 2012-12-26 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A201374-006 | LAMOTRIGINE | 300MG | TABLET, EXTENDED RELEASE / ORAL | 2012-12-26 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A201374-001 | LAMOTRIGINE | 25MG | TABLET, EXTENDED RELEASE / ORAL | 2012-12-26 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A201374-002 | LAMOTRIGINE | 50MG | TABLET, EXTENDED RELEASE / ORAL | 2012-12-26 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A201374-003 | LAMOTRIGINE | 100MG | TABLET, EXTENDED RELEASE / ORAL | 2012-12-26 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A201374-004 | LAMOTRIGINE | 200MG | TABLET, EXTENDED RELEASE / ORAL | 2012-12-26 | 03ed91905a0d… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A201374-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A201374-002 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A201374-003 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A201374-004 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A201374-005 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A201374-006 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A201374-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A201374-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A201374-003 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A201374-004 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A201374-005 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A201374-006 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A201374-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A201374-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A201374-003 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A201374-004 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A201374-005 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A201374-006 | AB | 1 | 31067a03dcf5… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A201374-001 | AB | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A201374-002 | AB | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A201374-003 | AB | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A201374-004 | AB | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A201374-005 | AB | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A201374-006 | AB | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A201374-001 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A201374-002 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A201374-003 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A201374-004 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A201374-005 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A201374-006 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A201374-001 | AB | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A201374-002 | AB | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A201374-003 | AB | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A201374-004 | AB | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A201374-005 | AB | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A201374-006 | AB | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A201374-001 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A201374-002 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A201374-003 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A201374-004 | AB | 1 | 74a2ff9319b5… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lamotrigine Extended-Release | LAMOTRIGINE | Par Health USA, LLC | d5ec4d58-c669-4ab4-ba62-b71007536854 | 2026-01-21 | Boxed warning, Warnings, Adverse reactions | 201374 ANDA201374 |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 22852 | ORIG | 2013-02-26 |